GENIXUS
Manufacturing · North Carolina, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
150 N Research Campus Dr, Kannapolis, No...Phone Number
(877) 436-4987Website
www.genixus.comRevenue
$5.2 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
2
1
1
1
1
About GENIXUS
At GENIXUS, were on a mission to elevate the business of acute and critical care medicines. Delivering innovative solutions which allow healthcare providers to focus on what really matters protecting and improving lives.Explore more
GENIXUS Org Chart
ND
Director, Human Resources
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is GENIXUS your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Product Launch: Get notified when GENIXUS launches new products
Website visits: Recent activity has been detected on your website
Check out if GENIXUS is spiking on competitors!
Click to see if GENIXUS had a recent Job posting/layoffs
Check if GENIXUS has recently received funding, and reach out quickly before it becomes old news!
Congratulate Masked Content for being promoted to Masked Content at GENIXUS
Earning: See what the market has to say on GENIXUS recently announced quarterly report
GENIXUS, which may be a good buyer, showed buying intent in Masked Content Topic
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once GENIXUS has new funding data
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 2 more new buyers
Compare Similar Companies to GENIXUS
Compare insights from companies similar to GENIXUS, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
GENIXUS is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
GENIXUS is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about GENIXUS.
GENIXUS financials insights
Gather financial insights about GENIXUS, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2022
Unspecified
$20M
GENIXUS Tech Stack
A closer look at the technologies used by GENIXUS
Most Recent Scoops
Open Position
Open Position
Open Position
GENIXUS is currently seeking a Director, Regulatory. (Kannapolis, NC)
Open Position
GENIXUS is currently seeking a Director, Quality Assurance. (Kannapolis, NC)
Funding
GENIXUS News & Media
Genixus™ Announces 340B Prime Vendor Contract with Apexus for KinetiX™ Propofol RTA Syringes
KANNAPOLIS, N.C.--(BUSINESS WIRE)--Genixus, a pharmaceutical company focused on transforming acute and critical care medicines, is pleased to announce the execution of a contract with the 340B Prime Vendor Program, managed by Apexus LLC., for KinetiX Propofol 1% ready-to-administer (RTA) syringes, designed to simplify workflow and support effective care delivery. KinetiX Propofol features several key attributes: Long-term shelf stability to support a hospital’s supply chain Intuitive labeling aGenixus™ Expands Manufacturing Capacity to Meet Demand for KinetiX™ RTA Syringes
KANNAPOLIS, N.C.--(BUSINESS WIRE)--Genixus, a pharmaceutical company focused on transforming acute and critical care medicines, today announced it is finalizing the buildout of a new manufacturing site in Concord, N.C., complete with automated manufacturing and cutting edge technology to support the KinetiX syringe platform and expanding portfolio. The added manufacturing capacity is in response to the marketplace demand for ready-to-administer (RTA) syringes. Production of the company’s firstKit Check Partners with Genixus™ to Introduce RFID-Tagged Propofol as the First Product Within the KinetiX™ Line of Ready-to-Administer Syringes
ALEXANDRIA, Va.--(BUSINESS WIRE)--Kit Check, the leading automation vendor in Medication Intelligence™, today announced that its proprietary Radio Frequency Identification (RFID) technology will be incorporated in the new KinetiX™ Propofol syringes being developed by Genixus™, a pharmaceutical company and FDA-registered repackager and 503B outsourcing provider focused on transforming acute and critical care medicines. Propofol is one of the most commonly used products in hospitals and health syGenixus™ Introduces Propofol as the First Product to be Delivered Within KinetiX™ Ready-to-Administer (RTA) Syringe Platform
New Propofol RTA Syringe, Designed to Simplify Use of the Product at Bedside, to Support Efforts toward Error Resistance LAS VEGAS, Aug. 9, 2022 /PRNewswire/ -- Genixus™, a pharmaceutical company focused on transforming acute and critical care medicines, today announced that it will offer...
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Frequently Asked Questions Regarding GENIXUS
Sign Up For FreeTo access detailed company insights
At GENIXUS, were on a mission to elevate the business of acute and critical care medicines. Delivering innovative solutions which allow healthcare providers to focus on what really matters protecting and improving lives.... Read More
